Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 48 of 544 entries
Sorted by: Best Match Show Resources per page
Factors affecting compliance to management of diabetes in Urban Health Center of a tertiary care teaching hospital of south India.

Journal of natural science, biology, and medicine

Santhanakrishnan I, Lakshminarayanan S, Kar SS.
PMID: 25097416
J Nat Sci Biol Med. 2014 Jul;5(2):365-8. doi: 10.4103/0976-9668.136186.

AIM: To Study the Factors affecting compliance to diabetes management and study risk factors and complications of type II diabetes.SETTINGS AND DESIGN: Primary health center, Descriptive study.MATERIALS AND METHODS: A descriptive study of previously diagnosed diabetics (n = 135)...

Cite
Santhanakrishnan I, Lakshminarayanan S, Kar SS. Factors affecting compliance to management of diabetes in Urban Health Center of a tertiary care teaching hospital of south India. J Nat Sci Biol Med. 2014;5(2):365-8doi: 10.4103/0976-9668.136186.
Santhanakrishnan, I., Lakshminarayanan, S., & Kar, S. S. (2014). Factors affecting compliance to management of diabetes in Urban Health Center of a tertiary care teaching hospital of south India. Journal of natural science, biology, and medicine, 5(2), 365-8. https://doi.org/10.4103/0976-9668.136186
Santhanakrishnan, Iswarya, et al. "Factors affecting compliance to management of diabetes in Urban Health Center of a tertiary care teaching hospital of south India." Journal of natural science, biology, and medicine vol. 5,2 (2014): 365-8. doi: https://doi.org/10.4103/0976-9668.136186
Santhanakrishnan I, Lakshminarayanan S, Kar SS. Factors affecting compliance to management of diabetes in Urban Health Center of a tertiary care teaching hospital of south India. J Nat Sci Biol Med. 2014 Jul;5(2):365-8. doi: 10.4103/0976-9668.136186. PMID: 25097416; PMCID: PMC4121916.
Copy Download .nbib Format: NLM
Effects of a 6-Month Exenatide Therapy on HbA1c and Weight in Korean Patients with Type 2 Diabetes: A Retrospective Cohort Study.

Diabetes & metabolism journal

Shin J, Chang JS, Kim HS, Ko SH, Cha BY, Son HY, Yoon KH, Cho JH.
PMID: 23130321
Diabetes Metab J. 2012 Oct;36(5):364-70. doi: 10.4093/dmj.2012.36.5.364. Epub 2012 Oct 18.

BACKGROUND: While many studies have shown the good efficacy and safety of exenatide in patients with diabetes, limited information is available about exenatide in clinical practice in Korean populations. Therefore, this retrospective cohort study was designed to analyze the...

Cite
Shin J, Chang JS, Kim HS, et al. Effects of a 6-Month Exenatide Therapy on HbA1c and Weight in Korean Patients with Type 2 Diabetes: A Retrospective Cohort Study. Diabetes Metab J. 2012;36(5):364-70doi: 10.4093/dmj.2012.36.5.364.
Shin, J., Chang, J. S., Kim, H. S., Ko, S. H., Cha, B. Y., Son, H. Y., Yoon, K. H., & Cho, J. H. (2012). Effects of a 6-Month Exenatide Therapy on HbA1c and Weight in Korean Patients with Type 2 Diabetes: A Retrospective Cohort Study. Diabetes & metabolism journal, 36(5), 364-70. https://doi.org/10.4093/dmj.2012.36.5.364
Shin, Juyoung, et al. "Effects of a 6-Month Exenatide Therapy on HbA1c and Weight in Korean Patients with Type 2 Diabetes: A Retrospective Cohort Study." Diabetes & metabolism journal vol. 36,5 (2012): 364-70. doi: https://doi.org/10.4093/dmj.2012.36.5.364
Shin J, Chang JS, Kim HS, Ko SH, Cha BY, Son HY, Yoon KH, Cho JH. Effects of a 6-Month Exenatide Therapy on HbA1c and Weight in Korean Patients with Type 2 Diabetes: A Retrospective Cohort Study. Diabetes Metab J. 2012 Oct;36(5):364-70. doi: 10.4093/dmj.2012.36.5.364. Epub 2012 Oct 18. PMID: 23130321; PMCID: PMC3486983.
Copy Download .nbib Format: NLM
Effect of herbal hypoglycemic agents on oxidative stress and antioxidant status in diabetic rats.

Indian journal of clinical biochemistry : IJCB

Mahdi AA, Chandra A, Singh RK, Shukla S, Mishra LC, Ahmad S.
PMID: 23105386
Indian J Clin Biochem. 2003 Jul;18(2):8-15. doi: 10.1007/BF02867361.

In the present study the antioxidative potential ofMomordica charantia, Azadirachta indica, Allium sativum andOcimum sanctum was assessed in streptozotocin induced diabetic rats. Lipid peroxide levels were also measured in normal, diabetic and treated animals. Malondialdehyde (MDA) levels were significantly...

Cite
Mahdi AA, Chandra A, Singh RK, et al. Effect of herbal hypoglycemic agents on oxidative stress and antioxidant status in diabetic rats. Indian J Clin Biochem. 2003;18(2):8-15doi: 10.1007/BF02867361.
Mahdi, A. A., Chandra, A., Singh, R. K., Shukla, S., Mishra, L. C., & Ahmad, S. (2003). Effect of herbal hypoglycemic agents on oxidative stress and antioxidant status in diabetic rats. Indian journal of clinical biochemistry : IJCB, 18(2), 8-15. https://doi.org/10.1007/BF02867361
Mahdi, Abbas Ali, et al. "Effect of herbal hypoglycemic agents on oxidative stress and antioxidant status in diabetic rats." Indian journal of clinical biochemistry : IJCB vol. 18,2 (2003): 8-15. doi: https://doi.org/10.1007/BF02867361
Mahdi AA, Chandra A, Singh RK, Shukla S, Mishra LC, Ahmad S. Effect of herbal hypoglycemic agents on oxidative stress and antioxidant status in diabetic rats. Indian J Clin Biochem. 2003 Jul;18(2):8-15. doi: 10.1007/BF02867361. PMID: 23105386; PMCID: PMC3453893.
Copy Download .nbib Format: NLM
The antidiabetic potentials of the methanolic seed extract of buchhlozia coriacea.

Annals of medical and health sciences research

Ezeigbo I.
PMID: 23209970
Ann Med Health Sci Res. 2011 Jul;1(2):159-63.

BACKGROUND: Diabetes mellitus has remained a significant contributor to morbidities and mortalities in our environment despite all efforts to curb the trend. Regrettably, conventional, orthodox hypoglycemic agents have remained unaffordable. Consequently the need for available and affordable alternatives cannot...

Cite
Ezeigbo I. The antidiabetic potentials of the methanolic seed extract of buchhlozia coriacea. Ann Med Health Sci Res. 2011;1(2):159-63
Ezeigbo, I. (2011). The antidiabetic potentials of the methanolic seed extract of buchhlozia coriacea. Annals of medical and health sciences research, 1(2), 159-63.
Ezeigbo, Ii. "The antidiabetic potentials of the methanolic seed extract of buchhlozia coriacea." Annals of medical and health sciences research vol. 1,2 (2011): 159-63.
Ezeigbo I. The antidiabetic potentials of the methanolic seed extract of buchhlozia coriacea. Ann Med Health Sci Res. 2011 Jul;1(2):159-63. PMID: 23209970; PMCID: PMC3507116.
Copy Download .nbib Format: NLM
Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients.

Journal of basic and clinical pharmacy

Agarwal AA, Jadhav PR, Deshmukh YA.
PMID: 25278671
J Basic Clin Pharm. 2014 Jun;5(3):79-83. doi: 10.4103/0976-0105.139731.

CONTEXT: Despite the availability of efficacious anti-diabetic drugs, which act by different mechanisms to reduce the blood-glucose, the majority of people with diabetes on anti-diabetic drug therapy, have poor glycemic control and diabetic vascular complications.AIM AND OBJECTIVES: The aim...

Cite
Agarwal AA, Jadhav PR, Deshmukh YA. Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients. J Basic Clin Pharm. 2014;5(3):79-83doi: 10.4103/0976-0105.139731.
Agarwal, A. A., Jadhav, P. R., & Deshmukh, Y. A. (2014). Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients. Journal of basic and clinical pharmacy, 5(3), 79-83. https://doi.org/10.4103/0976-0105.139731
Agarwal, Akshay A, et al. "Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients." Journal of basic and clinical pharmacy vol. 5,3 (2014): 79-83. doi: https://doi.org/10.4103/0976-0105.139731
Agarwal AA, Jadhav PR, Deshmukh YA. Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients. J Basic Clin Pharm. 2014 Jun;5(3):79-83. doi: 10.4103/0976-0105.139731. PMID: 25278671; PMCID: PMC4160724.
Copy Download .nbib Format: NLM
Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database.

ClinicoEconomics and outcomes research : CEOR

Mazzi S, Ravasio R, Forlani G, Veronese G, Fabbri A, Marchesini G.
PMID: 29200880
Clinicoecon Outcomes Res. 2017 Nov 21;9:711-720. doi: 10.2147/CEOR.S148368. eCollection 2017.

The primary objective of this study was to estimate 1) the annual risk of undergoing a severe hypoglycemic event in Italian patients with diabetes and 2) the risk of hospitalization following such event. From the HYPOTHESIS database, powered by...

Cite
Mazzi S, Ravasio R, Forlani G, et al. Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database. Clinicoecon Outcomes Res. 2017;9:711-720doi: 10.2147/CEOR.S148368.
Mazzi, S., Ravasio, R., Forlani, G., Veronese, G., Fabbri, A., & Marchesini, G. (2017). Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database. ClinicoEconomics and outcomes research : CEOR, 9711-720. https://doi.org/10.2147/CEOR.S148368
Mazzi, Silvio, et al. "Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database." ClinicoEconomics and outcomes research : CEOR vol. 9 (2017): 711-720. doi: https://doi.org/10.2147/CEOR.S148368
Mazzi S, Ravasio R, Forlani G, Veronese G, Fabbri A, Marchesini G. Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database. Clinicoecon Outcomes Res. 2017 Nov 21;9:711-720. doi: 10.2147/CEOR.S148368. eCollection 2017. PMID: 29200880; PMCID: PMC5701554.
Copy Download .nbib Format: NLM
Factors associated with non-proliferative diabetic retinopathy in patients with type 1 and type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study (JDCP study 4).

Diabetology international

Kawasaki R, Kitano S, Sato Y, Yamashita H, Nishimura R, Tajima N.
PMID: 30800559
Diabetol Int. 2018 Apr 26;10(1):3-11. doi: 10.1007/s13340-018-0357-z. eCollection 2019 Jan.

AIMS: This study aims to identify associations of non-proliferative diabetic retinopathy (NPDR) in the Japan Diabetes Complication and its Prevention prospective (JDCP) study, a nation-wide study capturing real-world practice for diabetes in Japan.METHODS: We recruited patients with type 1...

Cite
Kawasaki R, Kitano S, Sato Y, et al. Factors associated with non-proliferative diabetic retinopathy in patients with type 1 and type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study (JDCP study 4). Diabetol Int. 2018;10(1):3-11doi: 10.1007/s13340-018-0357-z.
Kawasaki, R., Kitano, S., Sato, Y., Yamashita, H., Nishimura, R., Tajima, N. (2019). Factors associated with non-proliferative diabetic retinopathy in patients with type 1 and type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study (JDCP study 4). Diabetology international, 10(1), 3-11. https://doi.org/10.1007/s13340-018-0357-z
Kawasaki, Ryo, et al. "Factors associated with non-proliferative diabetic retinopathy in patients with type 1 and type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study (JDCP study 4)." Diabetology international vol. 10,1 (2019): 3-11. doi: https://doi.org/10.1007/s13340-018-0357-z
Kawasaki R, Kitano S, Sato Y, Yamashita H, Nishimura R, Tajima N. Factors associated with non-proliferative diabetic retinopathy in patients with type 1 and type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study (JDCP study 4). Diabetol Int. 2018 Apr 26;10(1):3-11. doi: 10.1007/s13340-018-0357-z. eCollection 2019 Jan. PMID: 30800559; PMCID: PMC6357241.
Copy Download .nbib Format: NLM
Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats.

Diabetes & metabolism journal

Koothappan M, Vellai RD, Subramanian IP, Subramanian SP.
PMID: 29885106
Diabetes Metab J. 2018 Jun;42(3):244-248. doi: 10.4093/dmj.2018.0002. Epub 2018 Apr 24.

Due to the multifactorial and multisystemic nature of diabetes mellitus, it is often treated with a combination of therapeutic agents having different mode of action. Earlier, we have synthesized several organozinc complexes and evaluated their safety and antidiabetic properties...

Cite
Koothappan M, Vellai RD, Subramanian IP, et al. Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats. Diabetes Metab J. 2018;42(3):244-248doi: 10.4093/dmj.2018.0002.
Koothappan, M., Vellai, R. D., Subramanian, I. P., & Subramanian, S. P. (2018). Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats. Diabetes & metabolism journal, 42(3), 244-248. https://doi.org/10.4093/dmj.2018.0002
Koothappan, Muruganantham, et al. "Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats." Diabetes & metabolism journal vol. 42,3 (2018): 244-248. doi: https://doi.org/10.4093/dmj.2018.0002
Koothappan M, Vellai RD, Subramanian IP, Subramanian SP. Synthesis of a New Zinc-Mixed Ligand Complex and Evaluation of Its Antidiabetic Properties in High Fat Diet: Low Dose Streptozotocin Induced Diabetic Rats. Diabetes Metab J. 2018 Jun;42(3):244-248. doi: 10.4093/dmj.2018.0002. Epub 2018 Apr 24. PMID: 29885106; PMCID: PMC6015968.
Copy Download .nbib Format: NLM
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.

Annals of translational medicine

Mantovani A, Targher G.
PMID: 28758096
Ann Transl Med. 2017 Jul;5(13):270. doi: 10.21037/atm.2017.04.41.

The incidence of both type 2 diabetes mellitus (T2DM) and multiple cancer types are rapidly increasing worldwide. Several studies documented that T2DM is closely associated with an increased incidence of cancer. However, while some methodological considerations preclude a definitive...

Cite
Mantovani A, Targher G. Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. Ann Transl Med. 2017;5(13):270doi: 10.21037/atm.2017.04.41.
Mantovani, A., & Targher, G. (2017). Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. Annals of translational medicine, 5(13), 270. https://doi.org/10.21037/atm.2017.04.41
Mantovani, Alessandro, and Targher, Giovanni. "Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease." Annals of translational medicine vol. 5,13 (2017): 270. doi: https://doi.org/10.21037/atm.2017.04.41
Mantovani A, Targher G. Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. Ann Transl Med. 2017 Jul;5(13):270. doi: 10.21037/atm.2017.04.41. PMID: 28758096; PMCID: PMC5515814.
Copy Download .nbib Format: NLM
Chronic obstructive pulmonary disease and diabetes: a look at the epidemiology, pathogenetic mechanisms, treatment.

Patologicheskaia fiziologiia i eksperimental'naia terapiia

Kozhevnikova SA, Budnevskiy AV, Ovsyannikov ES, Malysh EY, Belov VN.
PMID: 29244933
Patol Fiziol Eksp Ter. 2016 Oct-Dec;60(4):122-7.

Lately, increasingly studied the negative impact of diabetes type 2 on chronic obstructive pulmonary disease (COPD). According to literary data diabetes type 2 is more often diagnosed in patients with COPD in comparison with the general population: diabetes type...

Cite
Kozhevnikova SA, Budnevskiy AV, Ovsyannikov ES, et al. Chronic obstructive pulmonary disease and diabetes: a look at the epidemiology, pathogenetic mechanisms, treatment. Patol Fiziol Eksp Ter. 2016;60(4):122-7
Kozhevnikova, S. A., Budnevskiy, A. V., Ovsyannikov, E. S., Malysh, E. Y., & Belov, V. N. (2016). Chronic obstructive pulmonary disease and diabetes: a look at the epidemiology, pathogenetic mechanisms, treatment. Patologicheskaia fiziologiia i eksperimental'naia terapiia, 60(4), 122-7.
Kozhevnikova, S A, et al. "Chronic obstructive pulmonary disease and diabetes: a look at the epidemiology, pathogenetic mechanisms, treatment." Patologicheskaia fiziologiia i eksperimental'naia terapiia vol. 60,4 (2016): 122-7.
Kozhevnikova SA, Budnevskiy AV, Ovsyannikov ES, Malysh EY, Belov VN. Chronic obstructive pulmonary disease and diabetes: a look at the epidemiology, pathogenetic mechanisms, treatment. Patol Fiziol Eksp Ter. 2016 Oct-Dec;60(4):122-7. PMID: 29244933.
Copy Download .nbib Format: NLM
Metformin Use and Metformin-associated Lactic Acidosis in Intensive Care Unit Patients with Diabetes.

Cureus

Rajasurya V, Anjum H, Surani S.
PMID: 31355098
Cureus. 2019 May 23;11(5):e4739. doi: 10.7759/cureus.4739.

Metformin is a very potent anti-diabetic drug that has become the drug of choice for the treatment of type 2 diabetes. In addition to its glucose-lowering properties, it also reduces all-cause mortality through its anti-inflammatory and cardioprotective effects. Although...

Cite
Rajasurya V, Anjum H, Surani S. Metformin Use and Metformin-associated Lactic Acidosis in Intensive Care Unit Patients with Diabetes. Cureus. 2019;11(5):e4739doi: 10.7759/cureus.4739.
Rajasurya, V., Anjum, H., & Surani, S. (2019). Metformin Use and Metformin-associated Lactic Acidosis in Intensive Care Unit Patients with Diabetes. Cureus, 11(5), e4739. https://doi.org/10.7759/cureus.4739
Rajasurya, Venkat, et al. "Metformin Use and Metformin-associated Lactic Acidosis in Intensive Care Unit Patients with Diabetes." Cureus vol. 11,5 (2019): e4739. doi: https://doi.org/10.7759/cureus.4739
Rajasurya V, Anjum H, Surani S. Metformin Use and Metformin-associated Lactic Acidosis in Intensive Care Unit Patients with Diabetes. Cureus. 2019 May 23;11(5):e4739. doi: 10.7759/cureus.4739. PMID: 31355098; PMCID: PMC6649884.
Copy Download .nbib Format: NLM
SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists.

Journal of clinical medicine research

Abdelgadir E, Rashid F, Bashier A, Ali R.
PMID: 29977418
J Clin Med Res. 2018 Aug;10(8):615-625. doi: 10.14740/jocmr3467w. Epub 2018 Jun 27.

Landmark trials on diabetes control have shown variable results in terms of cardiovascular benefits, with the majority showing a favorable effect of glycemic control on microvascular and, more recently, macrovascular complications. However, some trials pointed out a CV hazard...

Cite
Abdelgadir E, Rashid F, Bashier A, et al. SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists. J Clin Med Res. 2018;10(8):615-625doi: 10.14740/jocmr3467w.
Abdelgadir, E., Rashid, F., Bashier, A., & Ali, R. (2018). SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists. Journal of clinical medicine research, 10(8), 615-625. https://doi.org/10.14740/jocmr3467w
Abdelgadir, Elamin, et al. "SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists." Journal of clinical medicine research vol. 10,8 (2018): 615-625. doi: https://doi.org/10.14740/jocmr3467w
Abdelgadir E, Rashid F, Bashier A, Ali R. SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists. J Clin Med Res. 2018 Aug;10(8):615-625. doi: 10.14740/jocmr3467w. Epub 2018 Jun 27. PMID: 29977418; PMCID: PMC6031247.
Copy Download .nbib Format: NLM
Showing 37 to 48 of 544 entries